RxDoctor Payments Data

Richard Murphy, DO

Internal Medicine · Louisville, KYNPI 1083077515

Payments from drug & device makers

$1,302in general payments, 2019–2025

Across 77 payments — averaging $16.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$169
  • Amgen$160
  • Novartis$124
  • Pfizer$115
  • Arbor Pharmaceuticals, Inc.$115
  • Lilly USA, LLC$112
  • plus $507 from 12 others

What the payments were for

  • Food & beverage$1,24996%
  • Education$534%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,302 in reported general payments places this provider in the 65th percentile of 1,284 internal medicine providers in Kentucky.

See all internal medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$38,303
Medicare patients
218
Services billed
925

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide102$120,571
MounjaroTirzepatide97$116,948
EliquisApixaban83$98,131
OzempicSemaglutide36$67,067
XareltoRivaroxaban41$53,269
FarxigaDapagliflozin Propanediol47$49,653
GemtesaVibegron44$40,891
JardianceEmpagliflozin35$40,767
JanuviaSitagliptin Phosphate33$35,989
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$19,841
Breo ElliptaFluticasone/Vilanterol21$17,852
Repatha SureclickEvolocumab26$17,474
InvokanaCanagliflozin16$13,763
EdarbiAzilsartan Medoxomil17$12,018
Lagevrio (Eua)Molnupiravir16$11,115

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$112$237,519199 claims
PfizerEliquis$115$98,13183 claims
Novo NordiskOzempic$99$67,06736 claims
MerckJanuvia, Lagevrio (Eua), Janumet Xr$17$57,92461 claims
AstraZenecaFarxiga, Symbicort$169$53,64060 claims
Sumitomo Pharma America, Inc.Gemtesa$22$40,89144 claims
Boehringer IngelheimJardiance$15$40,76735 claims
GSKTrelegy Ellipta, Breo Ellipta$69$37,69347 claims
AbbVieLinzess, Restasis, Synthroid$61$26,153101 claims
Arbor Pharmaceuticals, Inc.Edarbi$115$12,01817 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,284 internal medicine providers in Kentucky.

Other internal medicine in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →